Hetero Healthcare’s COVID-19 Management portfolio reflects its commitment to supporting healthcare professionals and patients during the unprecedented challenges posed by the COVID-19 pandemic. The portfolio encompasses therapeutic solutions developed to support the clinical management of COVID-19, including antiviral and supportive treatment approaches used across different stages and severities of the infection, as clinically appropriate.
With a focus on addressing the evolving needs of COVID-19 care, Hetero Healthcare contributed to making critical therapies more accessible during the pandemic. The portfolio was aimed at supporting healthcare professionals in managing patients requiring timely medical intervention, while complementing established standards of care and treatment protocols.
Backed by Hetero Healthcare’s strengths in research, manufacturing, quality, and accessibility, the COVID-19 Management portfolio represents the organisation’s ability to respond to urgent public health needs. Through continued scientific focus and responsible healthcare delivery, Hetero Healthcare remains committed to supporting infectious disease management and contributing to better patient care.
View by-
